🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Treatment B (Budesonide metered dose inhaler)

Found 14 matching trials

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer

PHASE1

The primary purpose of this study is to demonstrate the equivalence of bude...

Status

Withdrawn

Location

Multiple Locations

Start Date

2024-10-17

Trial ID

NCT06340581

Treatments Being Tested

Treatment A: BGF MDI HFA Treatment B: BGF MDI HFO Treatment C: BGF MDI HFO AeroChamber Plus Flow-Vu Spacer

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

PHASE3

This study will investigate the effect of Budesonide, Glycopyrronium, and F...

Status

Completed

Location

Research Site

Start Date

2023-10-24

Trial ID

NCT06067828

Treatments Being Tested

Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate Treatment B: Budesonide and Formoterol Fumarate Treatment C : Placebo

A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.

PHASE1

This is a Phase 1 study to compare the pharmacokinetics of budesonide and a...

Status

Completed

Location

Research Site

Start Date

2019-01-21

Trial ID

NCT03772223

Treatments Being Tested

Treatment A (Budesonide/Albuterol Sulfate metered dose inhaler)Treatment B (Budesonide metered dose inhaler)Treatment C (Albuterol Sulfate metered dose inhaler)

A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma

PHASE1

The purpose of this study is to assess the pharmacokinetics (PK) and safety...

Status

Completed

Location

Research Site

Start Date

2026-03-05

Trial ID

NCT07433569

Treatments Being Tested

Budesonide/formoterol fumarate Aerosphere Budesonide/formoterol fumarate pMDI

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

PHASE2

The purpose of this study is to evaluate the effect of 2 different GP meter...

Status

Recruiting

Location

Research Site

Start Date

2026-04-14

Trial ID

NCT07525375

Treatments Being Tested

GP MDI BFF MDI Placebo MDI

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.

PHASE1

To compare the pharmacokinetics of budesonide delivered by BDA MDI to budes...

Status

Completed

Location

IPS Research

Start Date

2021-05-06

Trial ID

NCT04848662

Treatments Being Tested

BDA MDI (PT027) 160/180 μg Pulmicort Respules 0.5 MG/ML Inhalation Suspension

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma

PHASE3

The purpose of this Phase III, multicentre, randomized, double-blind, singl...

Status

Completed

Location

Research Site

Start Date

2023-12-22

Trial ID

NCT06245551

Treatments Being Tested

Budesonide/albuterol metered-dose inhaler 160/180 μg Placebo metered-dose inhaler

A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

PHASE1

This study will be conducted to establish the relative bioavailability of b...

Status

Completed

Location

Research Site

Start Date

2016-11-04

Trial ID

NCT02934607

Treatments Being Tested

Symbicort pMDI with spacer device Symbicort pMDI without spacer device

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

PHASE1

The study will evaluate bioavailability, pharmacokinetics, safety, and tole...

Status

Completed

Location

Research Site

Start Date

2020-10-19

Trial ID

NCT04600505

Treatments Being Tested

Treatment A Treatment B Treatment C

A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer

PHASE1

This study aims to assess the effect on total systemic exposure and to char...

Status

Completed

Location

Research Site

Start Date

2024-04-29

Trial ID

NCT06297668

Treatments Being Tested

Treatment A: BGF MDI HFA Treatment B: BGF MDI HFO Treatment C: BGF MDI HFO AeroChamber Plus Flow-Vu spacer

Previous Next